1 asset in Leptomeningeal Melanoma
Therapeutic assets addressing Leptomeningeal Melanoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
her2bbζ/cd19t+ t cells Leptomeningeal Melanoma | M.D. Anderson Cancer Center | P1 | CC (43) |